<svg style="vertical-align:-0.17998pt;width:49.1875px;" id="M1" height="20.112499" version="1.1" viewBox="0 0 49.1875 20.112499" width="49.1875"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,20.1125)">
		<g transform="translate(72,-55.91)">
			<text transform="matrix(1,0,0,-1,-71.95,63.31)">
				<tspan style="font-size: 12.55px; " x="0" y="0">𝟏</tspan>
				<tspan style="font-size: 12.55px; " x="6.2765002" y="0">𝟖</tspan>
				<tspan style="font-size: 12.55px; " x="12.553" y="0">𝟖</tspan>
			</text>

			<text transform="matrix(1,0,0,-1,-52.62,56.14)">
				<tspan style="font-size: 17.93px; " x="0" y="0">R</tspan>
				<tspan style="font-size: 17.93px; " x="11.961311" y="0">e</tspan>
			</text>

		</g>
	</g>
</svg>-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside

<table><i>Ex vivo</i> biodistribution of <sup>188</sup>Re-SSS/Lipiodol in healthy pigs (<svg height="11.125" id="M17" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,10.863)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2
q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,0,0,-.017,13.305,10.863)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,0,0,-.017,28.008,10.863)"><path d="M412 140l28 -9q0 -2 -35 -131h-373v23q112 112 161 170q59 70 92 127t33 115q0 63 -31 98t-86 35q-75 0 -137 -93l-22 20l57 81q55 59 135 59q69 0 118.5 -46.5t49.5 -122.5q0 -62 -29.5 -114t-102.5 -130l-141 -149h186q42 0 58.5 10.5t38.5 56.5z" id="x32"></path></g>
</svg> for each time point).</table>

International Journal of Molecular Imaging

fig9

Figure 9

Figure 9: <svg style="vertical-align:-0.17998pt;width:49.1875px;" id="M1" height="20.112499" version="1.1" viewBox="0 0 49.1875 20.112499" width="49.1875"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,20.1125)">
		<g transform="translate(72,-55.91)">
			<text transform="matrix(1,0,0,-1,-71.95,63.31)">
				<tspan style="font-size: 12.55px; " x="0" y="0">𝟏</tspan>
				<tspan style="font-size: 12.55px; " x="6.2765002" y="0">𝟖</tspan>
				<tspan style="font-size: 12.55px; " x="12.553" y="0">𝟖</tspan>
			</text>

			<text transform="matrix(1,0,0,-1,-52.62,56.14)">
				<tspan style="font-size: 17.93px; " x="0" y="0">R</tspan>
				<tspan style="font-size: 17.93px; " x="11.961311" y="0">e</tspan>
			</text>

		</g>
	</g>
</svg>-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside 

Figure 9 | 
	
		
			
				𝟏
				𝟖
				𝟖
			

			
				R
				e
			

		
	
-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside 

International Journal of Molecular Imaging

𝟏 𝟖 𝟖 R e -SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside

Figure 9

-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside